AN2 Therapeutics, Inc. ($ANTX)
Filing Information
| Accession Number | 0001193125-26-301092 |
|---|---|
| Form Type | 4 |
| Filing Date | Jul 10, 2026 |
| Document | View SEC Filing |
Transactions
1
Total Shares
5,945
Total Value
$24,802.54
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Operating Officer and Chief Legal Officer | Common Stock | โ | Jul 8, 2026 | Sale | 5,945 | $4.17 | $24,802.54 | 206,554 | Direct | โ | View Details |